AU2002347336A1 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
AU2002347336A1
AU2002347336A1 AU2002347336A AU2002347336A AU2002347336A1 AU 2002347336 A1 AU2002347336 A1 AU 2002347336A1 AU 2002347336 A AU2002347336 A AU 2002347336A AU 2002347336 A AU2002347336 A AU 2002347336A AU 2002347336 A1 AU2002347336 A1 AU 2002347336A1
Authority
AU
Australia
Prior art keywords
quinoline derivatives
quinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002347336A
Inventor
Kevin Michael Foote
Keith Hopkinson Gibson
Laurent Francois Andre Hennequin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002347336A1 publication Critical patent/AU2002347336A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2002347336A 2001-12-05 2002-12-05 Quinoline derivatives Abandoned AU2002347336A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01403124.9 2001-12-05
EP01403124 2001-12-05
PCT/GB2002/005493 WO2003048159A1 (en) 2001-12-05 2002-12-05 Quinoline derivatives

Publications (1)

Publication Number Publication Date
AU2002347336A1 true AU2002347336A1 (en) 2003-06-17

Family

ID=8182999

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002347336A Abandoned AU2002347336A1 (en) 2001-12-05 2002-12-05 Quinoline derivatives

Country Status (2)

Country Link
AU (1) AU2002347336A1 (en)
WO (1) WO2003048159A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849625B2 (en) 2000-10-13 2005-02-01 Astrazeneca Ab Quinazoline derivatives with anti-tumour activity
EP1326860A1 (en) 2000-10-13 2003-07-16 AstraZeneca AB Quinazoline derivatives
US7501516B2 (en) 2001-07-16 2009-03-10 Astrazeneca Ab Quinoline derivatives and their use as tyrosine kinase inhibitors
EP2280003B1 (en) 2002-07-15 2014-04-02 Symphony Evolution, Inc. Process for preparing receptor-type kinase modulators
GB0225579D0 (en) 2002-11-02 2002-12-11 Astrazeneca Ab Chemical compounds
GB0318422D0 (en) * 2003-08-06 2003-09-10 Astrazeneca Ab Chemical compounds
DK2210607T3 (en) 2003-09-26 2011-12-12 Exelixis Inc N- [3-fluoro-4 - ({6- (methyloxy) -7 - [(3-morpholin-4-ylpropyl) oxy] quinolin-4-yl} oxy) phenyl] -N '- (4-fluorophenyl) cyclopropane-1,1-dicarboxamide for the treatment of cancer
WO2009021965A2 (en) 2007-08-15 2009-02-19 Glaxo Group Limited Substituted quinoline derivatives as h1 receptor antagonists
US7829574B2 (en) * 2008-05-09 2010-11-09 Hutchison Medipharma Enterprises Limited Substituted quinazoline compounds and their use in treating angiogenesis-related diseases
MA32965B1 (en) 2009-01-12 2012-01-02 Pfizer Ltd SULFONAMIDE DERIVATIVES
WO2010083414A1 (en) 2009-01-16 2010-07-22 Exelixis, Inc. Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer
UA108618C2 (en) 2009-08-07 2015-05-25 APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT
CA2804173C (en) 2010-07-09 2015-01-13 Pfizer Limited Sulfonamide nav1.7 inhibitors
CN103819343B (en) * 2014-02-17 2016-03-23 青岛农业大学 The preparation method of the fluoro-6-nitrophenols of compound 2-allyl group-4-and agricultural biological activity
WO2016016894A1 (en) 2014-07-30 2016-02-04 Yeda Research And Development Co. Ltd. Media for culturing pluripotent stem cells
BR112018006873A2 (en) 2015-10-05 2018-11-06 The Trustees Of Columbia University In The City Of New York autophageal flow activators and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
EP3914698A1 (en) 2019-01-23 2021-12-01 Yeda Research and Development Co. Ltd Culture media for pluripotent stem cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73073C2 (en) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Substituted 3-cyan chinolines
GB9910577D0 (en) * 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
WO2003048159A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2002349676A1 (en) 4-oxoquinoline derivatives
HK1061810A1 (en) Tetrahydroquinoline derivatives
AU2002352142A1 (en) Pyrazolopyridine derivatives
AUPR975601A0 (en) Quinazolinone derivatives
AU2002347336A1 (en) Quinoline derivatives
AU2002331707A1 (en) Tetrahydroquinoline derivatives as antithrombotic agents
AU2002347359A1 (en) Quinoline derivatives
GB0104422D0 (en) Quinoline derivative
AU2003274551A1 (en) Quinoline derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2002365664A1 (en) Quinoline derivatives as antitumour agents
AU2003252333A1 (en) Novel tetrahydroquinoline derivatives
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2002233664A1 (en) Naphthyridine derivative
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2002325368A1 (en) Benzoylcyclohexenone derivatives
AU2002354530A1 (en) 4-phenylpyran-2-one derivatives
AU2002230196A1 (en) Dicarba-closo-dodecarborane derivatives
AU2002225034A1 (en) Rustmicin derivatives
AU2002253080A1 (en) Biurethane derivatives
AU2002249205A1 (en) Bis-triazinylaminobenzoxazole derivatives
AU2002255269A1 (en) 2-Iminopyrrolidine derivatives
AU2002302578A1 (en) Amido-diphenyl derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase